LEPR and breast cancer: We further identified that the genotype of LEPR rs1137101 was associated with decreased breast cancer risk under the dominant genetic model in the subgroup of WHR ≥ 0.85 regardless of BMI by stratified analysis (Table 4 and Supplementary Table 4).